Founded by life sciences venture capital firm ATP and renowned scientists at the University of California San Francisco (UCSF), Nine Square is uniting machine learning-enabled image-based cell profiling, chemistry and computational sciences to develop more effective drugs, faster.
We are building a diversified portfolio of first-in class drug candidates for genetically validated targets on the autophagy/lysosomal pathway to overcoming the historical challenges of treating severe neurodegenerative diseases. We are currently advancing multiple programs through preclinical development, with lead optimization efforts underway towards IND-enabling studies.
Company Details
- Employees
- 15
- Founded
- 2020
- Address
- 285 East Grand Avenue,
- Industry
- Biotechnology
- Website
- https://www.ninesquaretx.com
- Keywords
- Manager jobs.
- HQ
- South San Francisco, CA
Nine Square Therapeutics Questions
Nine Square Therapeutics's website is https://www.ninesquaretx.com
Nine Square Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nine-square-therapeutics
Nine Square Therapeutics has
15 employees.
View email and phone details for 15
employees at Nine Square Therapeutics.
Nine Square Therapeutics's industry is
Biotechnology
Nine Square Therapeutics's top competitors are
Evercrisp Biosciences,
Ascidian Therapeutics,
Siteone Therapeutics, Inc.,
Nurix Therapeutics,
Deep Apple Therapeutics,
Circle Pharma, Inc.,
Initial Therapeutics,
Atp (Apple Tree Partners),
Apertor Pharmaceuticals,
Maze Therapeutics.
Nine Square Therapeutics's categories are Biotechnology
Nine Square Therapeutics's founding year is 2020
